Insider · CIK 0001820885

BOBULSKY SUSAN

Reports to the SEC for 1 company · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001820885

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-06	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Officer, MRD	SSale	−6,444 sh	$30.00	−$193K	389,350
2026-09-15	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Officer, MRD	SSale	−1,195 sh	$27.00	−$32.3K	395,794
2026-08-10	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Officer, MRD	SSale	−3,000 sh	$25.00	−$75K	396,989
2026-07-30	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Officer, MRD	SSale	−1,299 sh	$24.00	−$31.2K	399,989
2026-07-16	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Officer, MRD	SSale	−5,000 sh	$23.00	−$115K	401,288
2026-07-01	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Officer, MRD	SSale	−487 sh	$22.00	−$10.7K	406,288
2026-06-25	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Officer, MRD	SSale	−5,000 sh	$20.50	−$103K	406,775
2026-06-11	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Officer, MRD	SSale	−5,000 sh	$19.00	−$95K	411,775
2026-06-04	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Officer, MRD	SSale	−11K sh	$18.00	−$198K	416,775
2026-03-11	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Officer, MRD	SSale	−41.3K sh	$13.17	−$544K	427,775
2026-03-04	ADPTAdaptive Biotechnologies CorpA Award	Chief Commercial Officer, MRD	AAward	+62.5K sh	—	—	469,113
2026-03-04	ADPTAdaptive Biotechnologies CorpA Award	Chief Commercial Officer, MRD	AAward	+59.4K sh	—	—	406,613
2025-03-05	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Officer, MRD	SSale	−26K sh	$6.98	−$182K	347,238
2025-03-04	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award	Chief Commercial Officer, MRD	AAward	+180K sh	—	—	180,029
2025-03-04	ADPTAdaptive Biotechnologies CorpA Award	Chief Commercial Officer, MRD	AAward	+120K sh	—	—	373,261
2024-10-08	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Chief Commercial Officer, MRD	MExercise/Conversion	−5,000 sh	—	—	0
2024-10-08	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Officer, MRD	MExercise/Conversion	+5,000 sh	$1.98	+$9,900	253,290
2024-03-05	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Officer, MRD	SSale	−6,975 sh	$3.44	−$24K	248,290
2024-03-05	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Officer, MRD	SSale	−6,016 sh	$3.43	−$20.6K	255,265
2024-03-04	ADPTAdaptive Biotechnologies CorpA Award	Chief Commercial Officer, MRD	AAward	+133K sh	—	—	261,281
2024-03-04	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award	Chief Commercial Officer, MRD	AAward	+200K sh	—	—	199,549
2021-03-04	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)A Award	Chief Commercial Officer, MRD	AAward	+22.9K sh	—	—	22,894
2021-03-04	ADPTAdaptive Biotechnologies CorpA Award	Chief Commercial Officer, MRD	AAward	+9,158 sh	—	—	9,158
2020-12-10	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer, MRD	MExercise/Conversion	−25K sh	—	—	30,000
2020-12-10	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Officer, MRD	SSale	−25K sh	$55.00	−$1.38M	0
2020-12-10	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Officer, MRD	MExercise/Conversion	+25K sh	$1.98	+$49.5K	25,000
2020-09-29	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Chief Commercial Officer, MRD	MExercise/Conversion	+10K sh	$1.98	+$19.8K	10,000
2020-09-29	ADPTAdaptive Biotechnologies CorpS Sale	Chief Commercial Officer, MRD	SSale	−10K sh	$50.00	−$500K	0
2020-09-29	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer, MRD	MExercise/Conversion	−10K sh	—	—	55,000
2020-08-13	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)A Award	Chief Commercial Officer, MRD	AAward	+20K sh	—	—	20,000

Recent filings

Accepted (ET)
Oct 8 18:524
BOBULSKY SUSAN0001820885-26-000025
SEC(opens sec.gov)
Sep 174
BOBULSKY SUSAN0001820885-26-000023
SEC(opens sec.gov)
Aug 124
BOBULSKY SUSAN0001820885-26-000020
SEC(opens sec.gov)
Aug 34
BOBULSKY SUSAN0001820885-26-000018
SEC(opens sec.gov)
Jul 204
BOBULSKY SUSAN0001820885-26-000016
SEC(opens sec.gov)
Jul 64
BOBULSKY SUSAN0001820885-26-000014
SEC(opens sec.gov)
Jun 294
BOBULSKY SUSAN0001820885-26-000012
SEC(opens sec.gov)
Jun 154
BOBULSKY SUSAN0001820885-26-000010
SEC(opens sec.gov)
Jun 84
BOBULSKY SUSAN0001820885-26-000008
SEC(opens sec.gov)
Mar 134
BOBULSKY SUSAN0001820885-26-000004
SEC(opens sec.gov)
Mar 64
BOBULSKY SUSAN0001820885-26-000002
SEC(opens sec.gov)
Mar 64
BOBULSKY SUSAN0001062993-25-004817
SEC(opens sec.gov)
Oct 104
BOBULSKY SUSAN0001062993-24-017564
SEC(opens sec.gov)
Mar 64
BOBULSKY SUSAN0001062993-24-005757
SEC(opens sec.gov)

Companies

Adaptive Biotechnologies CorpChief Commercial Officer, MRDADPT

Address

C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVENUE EAST

SEATTLE, WA, 98109